See also this year's filing and all EDGAR filings for this company.
PDF Report 0001159019_2015_Tribute_Pharmaceuticals_Canada_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'IncomeLossFromContinuingOperations'} |
Graph
Absolute values for 0001159019, Tribute Pharmaceuticals Canada Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 7,150,347 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 44,557,947 |
| 2 | PropertyPlantAndEquipmentNet | 1,012,285 |
| 3 | remainder_Assets | 359,161 |
| 4 | LiabilitiesCurrent | 8,771,516 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 13,967,493 |
| 7 | CostOfGoodsAndServicesSold | 1,961,098 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,500,928 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 9,060,547 |
| 11 | remainder_Revenues | 20,487,400 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -3,397,126 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 53,079,740 |
| 1 | Liabilities | 22,739,009 |
| 2 | Expenses | 21,522,573 |
| 3 | Revenues | 20,487,400 |
| 4 | StockholdersEquity | 30,340,731 |
| 5 | NetIncome | -1,035,173 |
| 6 | ComprehensiveNetIncome | -2,733,736 |
| 7 | BaseVar | 60,612,924 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.67 |
| 9 | EconomicCapitalRatio | 2.80 |
Edgar->Model Mapping
Feature Distribution
Change over Time
